Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Nichi-Iko Achieves Double Digit Increase In Sales And Profit

This article was originally published in PharmAsia News

Executive Summary

Nichi-Iko announced annual financial results for 2008, and the company's sales increased by 32.5 percent to ¥42.84 billion. Business profit increased by 24.1 percent to ¥30.95 billion, current earnings increased by 21.7 percent to ¥5.44 billion, and net profit increased by 31.5 percent to ¥3.44 billion. The numbers set new records for the company. Nichi-Iko also gained in market share, sales from wholesaler distribution increased by 40.9 percent to ¥30.9 billion. The company estimates a growing generic market and strong business results for 2009. (Click here for more - Japanese language

Latest Headlines
See All
UsernamePublicRestriction

Register

SC069839

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel